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H. pylori
 
 mobilizes cells
 
elicobacter pylori
 
 infects the gastric track of 
more than half of the human population 
and is associated with an increased occurrence of 
invasive gastric cancers. On page 249, Churin et 
al. explain how this widespread bug turns tu-
mors metastatic by corrupting a growth factor re-
ceptor.
H
H. pylori infection mobilizes gastric 
epithelial cells (right) by activating 
c-Met.
 
H. pylori
 
 mobilizes infected epithelial cells on its course to pathogenicity. The authors 
now show that mobilization results from activation of the hepatocyte growth factor 
(HGF) receptor c-Met. During development and differentiation, HGF-induced activation 
of c-Met initiates cell migration events. Inhibition of c-Met expression by siRNA blocks 
 
H. pylori
 
–induced motility. 
 
H. pylori
 
 corrupts c-Met signaling, however, by injecting 
host cells with the protein CagA. Binding of CagA to c-Met resulted in modulation of 
receptor activity and recruitment of PLC
 
 
 
, a mediator of cell polarity necessary for 
motility. CagA–PLC
 
 
 
 interactions mobilized infected cells through an ERK-dependent 
MAP kinase pathway, as inhibitors of MAP kinases or PLC
 
 
 
 blocked motility.
Unlike the gastric tumor cell line, a polarized canine kidney cell line does scatter in 
response to HGF. 
 
H pylori
 
 also induced c-Met–mediated motility in these cells, but 
did so through a PI3K-dependent pathway rather than through PLC
 
 
 
, indicating 
that the bug uses alternative routes to motility depending on the cell type. The authors 
hope to look at animal models next to determine whether inappropriate activation of 
c-Met and the resulting mobilization of gastric cells is responsible for increased incidences 
of metastatic cancers in 
 
H. pylori
 
 infections. 
 
 
 
Say NO to insulin
 
nsulin stimulates its own 
secretion from pancreatic 
 
 
 
 
cells through rapid nitrosylation 
of glucokinase (GK), according 
to results by Rizzo and Piston on 
page 243.
When glucose levels are low, an 
inhibited form of GK associates 
with insulin-containing granules 
in pancreatic 
 
 
 
 cells. Rizzo and 
Piston have determined that this 
localization is mediated through 
interaction with neuronal nitric 
oxide synthase (nNOS). Insulin 
treatment disrupted this association 
through nitrosylation of a GK 
cysteine residue. Activation of 
nNOS and the resulting nitro-
sylation of GK may be mediated 
through a rise in intracellular 
calcium, a known response of 
 
 
 
 
cells to insulin treatment. Release 
of the enzyme into the cytoplasm 
and the accompanying conform-
ational change—both of which 
required NO production—
activated GK.
GK induces secretion of the 
granules, thus promoting local 
increases in insulin levels. A 
recently developed drug for the 
treatment of type II diabetes is a 
GK activator. The new results 
suggest that the drug may activate 
GK by preventing granule binding. 
Piston plans to test this possibility 
in the near future. 
 
 
I
NO regulates association of GK (yellow) 
with insulin secretory granules (blue).
 
Choosing replication origins
 
fter mitosis, cells prepare for the next round of DNA replication by assembling 
complexes of proteins on chromatin that will carry out the task of copying the 
genome. Prereplication complexes (preRCs) assemble during telophase, but studies of 
the dihydrofolate reductase locus in mammalian cells have indicated that, during G1, 
only a subset of preRCs are designated for use as origins of replication. On page 257, 
Li et al. demonstrate that the same is true for origins throughout the genome.
 
 
 
Li et al. compared origins used by mammalian cells in 
vivo with those chosen in isolated mammalian nuclei 
undergoing premature replication in frog cytoplasmic 
extracts. Comparison of the two sets of origins revealed 
that, soon after mitosis, few of the sites used matched. 
About two hours after mitosis, the sites used in vitro were 
clustered into domains surrounding in vivo sites, but the 
actual sites fired still did not necessarily correspond. This 
domain selection was previously suggested by examinations 
of the timing of replication of whole chromosomal domains 
and is known as the timing decision point.
 Five hours after mitosis, the sites chosen in vitro were more 
likely to be the same sites used in vivo. This site selection is 
known as the origin decision point. Thus, as for the DHFR 
locus, the general choice of origins used is not random, but 
why origin selection should be regulated is unclear. Perhaps origins are placed near 
genes that encode replication proteins so that they are activated early by passage of 
the replication fork. Alternatively, origins may be regulated to prevent collision of RNA 
and DNA polymerases. If the latter is true, origin choice may change during differenti-
ation to accommodate transcriptional differences.
 
 
 
 
A
Replication origins in vitro 
(red) and in vivo (green).
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